| Gene symbol | XIAP | Synonyms | API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq25 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | X-linked inhibitor of apoptosis | ||||
| GTO ID | GTC1260 |
| Trial ID | NCT00385775 |
| Disease | Advanced Cancer |
| Altered gene | XIAP |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AEG35156 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | A Phase I Trial of AEG35156 Administered by 2-Hour Intravenous Infusion in Patients With Advanced Cancers |
| Year | 2006 |
| Country | United Kingdom |
| Company sponsor | Aegera Therapeutics |
| Other ID(s) | AEG35156-104 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||